SCHEMBL29917075

SCHEMBL29917075

CCc1cccc(S(=O)(=O)NC(=O)c2ccc(C(C)(C)C)nc2-c2ccc(C)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.48
PTGS1 P23219 1/20 0.48
EGFR P00533 4/20 0.44
PPARG P37231 1/20 0.43
PKM P14618 1/20 0.43
FLT1 P17948 4/20 0.43
FLT4 P35916 4/20 0.43
KDR P35968 4/20 0.43
FBP1 P09467 2/20 0.42
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
ERBB2 P04626 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.39
KIF18A Q8NI77 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17649366 1.00 PTGS2 (0.48) PTGS2PTGS1EGFRPPARGPKM
SCHEMBL29915847 0.88 PTGS2 (0.50) PTGS2PTGS1EGFRFLT1FLT4
SCHEMBL17647695 0.88 PTGS2 (0.50) PTGS2PTGS1EGFRFLT1FLT4
SCHEMBL29917888 0.87 KIF18A (0.41) PTGS2PTGS1EGFRPPARGFLT1
SCHEMBL17647883 0.87 KIF18A (0.41) PTGS2PTGS1EGFRPPARGFLT1
SCHEMBL29915808 0.87 PTGS2 (0.49) PTGS2PTGS1EGFRFLT1FLT4
SCHEMBL17647834 0.87 PTGS2 (0.49) PTGS2PTGS1EGFRFLT1FLT4
SCHEMBL17647991 0.86 PTGS2 (0.55) PTGS2PTGS1EGFRFLT1FLT4
SCHEMBL29916780 0.85 FLT1 (0.54) PTGS2PTGS1EGFRFLT1FLT4
SCHEMBL17649941 0.85 FLT1 (0.54) PTGS2PTGS1EGFRFLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3798214-B1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2022-09-14 EP claimed